In this article, we are going to take a look at where Soleno Therapeutics, Inc. (NASDAQ:SLNO) stands against other top small ...

Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Soleno Therapeutics in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the company ...

Over the last week, the United States market saw a 3.1% increase, contributing to a 24% climb over the past year, with earnings forecasted to grow by 15% annually. In this environment of robust growth ...

Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) last announced its earnings results on Wednesday, November 6th.The company reported ($1.83) EPS for the quarter, missing analysts’ consensus ...

In this article, we are going to take a look at where Soleno Therapeutics, Inc. (NASDAQ:SLNO) stands against other top small cap stocks to buy with the highest upside potential. What Would 2025 ...

REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the ...

Baird noted Soleno Therapeutics (SLNO) shares have traded, directionally, with Applied Therapeutics shares over the last couple of trading days, as they are both FDA regulatory plays on non ...

In trading on Wednesday, shares of Soleno Therapeutics Inc (Symbol: SLNO) crossed above their 200 day moving average of $47.25, changing hands as high as $48.43 per share. Soleno Therapeutics Inc ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company with a market capitalization of $2 billion specializing in rare disease treatments, stands at a pivotal juncture as it awaits ...